Related Experiment Video
Updated: Jun 9, 2025

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Characterization of a novel lytic phage against methicillin resistance Staphylococcus aureus in Hainan island
Yanmei Li1, Yue Zhang1, Anyang Li1
1School of Tropical Medicine, Hainan Medical University, Haikou, 571199, China.
Abstract:
Methicillin resistance Staphylococcus aureus (MRSA) is currently threatening global public health, and a similar issue was encountered in Hainan. For establishing a promising alternative therapeutic option, a phage with the capacity of lysing 18 out of 35 MRSA clinical isolates was recovered from domestic natural sources, which was termed as vB_SauP_L1 due to its morphology and genomic similarity with Rountreeviridae. Satisfactory proliferation rate and environmental tolerance were demonstrated by subsequent infectious properties tests and stability assessments. Sequencing revealed that its genome consisted of a linear double-stranded DNA of 17,114 bp, in which neither virulent nor resistant gene was detected, indicating its potential in MRSA prevention and treatment.
Insights
A novel bacteriophage, vB_SauP_L1, effectively targets Methicillin-resistant Staphylococcus aureus (MRSA). This phage shows promise as a safe and effective alternative for combating MRSA infections, a growing global health concern.
Area of Science:
- Microbiology
- Virology
- Infectious Diseases
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global public health threat.
- Hainan province faces challenges with MRSA infections, necessitating alternative therapeutic strategies.
Purpose of the Study:
- To isolate and characterize a bacteriophage with lytic activity against MRSA.
- To evaluate the potential of the isolated phage as a therapeutic agent for MRSA infections.
Main Methods:
- Isolation of bacteriophage vB_SauP_L1 from natural sources.
- Assessment of phage morphology and genomic characteristics.
- Evaluation of phage proliferation rate, environmental tolerance, and stability.
- Genomic sequencing to identify virulence or resistance genes.
Main Results:
- Phage vB_SauP_L1 lysed 18 out of 35 clinical MRSA isolates.
- The phage demonstrated satisfactory proliferation and environmental stability.
- Genomic analysis revealed a 17,114 bp linear double-stranded DNA genome.
- No virulent or antibiotic resistance genes were detected in the phage genome.
Conclusions:
- Phage vB_SauP_L1 is a promising candidate for MRSA therapeutic applications.
- The absence of harmful genes supports its safety profile for clinical use.
- This phage represents a potential alternative strategy for MRSA prevention and treatment.
More Related Videos
03:33Author Spotlight: An Adapted Optical Density-Based Microplate Assay for Characterizing Actinobacteriophage Infection
Published on: June 30, 2023
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
Related Concept Videos
Lytic Cycle of Bacteriophages
Viral Replication: Lytic Cycle
Lysogenic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle